SETD2 and nonpapillary renal cell carcinoma: Knockout of SETD2 in the 786-0 ccRCC cell line results in increased expression of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and higher mitochondrial mass, leading to the rerouting of glutamine metabolism (Liu et al., 2019).